Prosthetic Performance Enhancement Trial

NCT06419920 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2025-12-24

No results posted yet for this study

Summary

The purpose of this research is to determine the feasibility of an uneven terrain walking program for lower limb prosthesis users. The training is designed to induce step-to-step variability during walking within a safe environment, with the aim of improving walking skill and confidence.

Conditions

  • Amputation
  • Lower Limb Amputation Below Knee (Injury)
  • Lower Limb Amputation Above Knee (Injury)
  • Lower Limb Amputation at Ankle (Injury)
  • Lower Limb Amputation Knee
  • Lower Limb Amputation at Hip (Injury)

Interventions

OTHER

Flat terrain locomotor training

The training will be comprised of up to 12 sets of 2-min continuous walking on a level treadmill or mat, interspersed with rest breaks of at least one minute. Training will be completed three times per week for four weeks.

OTHER

Uneven terrain locomotor training

The training will be comprised of up to 12 sets of 2-min continuous walking on an uneven terrain treadmill or mat, interspersed with rest breaks of at least one minute. Training will be completed three times per week for four weeks.

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER
  • Chapman University

    collaborator OTHER
  • United States Department of Defense

    collaborator FED
  • National Institutes of Health (NIH)

    collaborator NIH
  • University of Nevada, Las Vegas

    lead OTHER

Principal Investigators

  • Jenny A Kent, PhD, CSci · University of Nevada, Las Vegas

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-26
Primary Completion
2026-11-30
Completion
2026-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06419920 on ClinicalTrials.gov